[{"address1": "1489 W. Warm Springs Road", "address2": "Suite 110", "city": "Henderson", "state": "NV", "zip": "89014", "country": "United States", "phone": "702 825 9872", "website": "https://zurabio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States. The company develops Tibulizumab, an immunoglobulin G-single-chain variable fragment bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes interleukin (IL)-17A and B-cell activating factor, which is in Phase 2 clinical trial development. It is also developing Torudokimab (ZB-880), a monoclonal antibody that neutralizes IL-33 to prevent ST2-dependent and ST2-independent inflammation, which has completed Phase 1/2 clinical studies; and Crebankitug (ZB-168), a monoclonal antibody that binds and neutralizes the IL-7 receptor alpha chain that impact on diseases driven by IL-7 and thymic stromal lymphopoietin immune pathways, which has completed Phase 1/1b clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Lisicki", "age": 57, "title": "CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 854212, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Someit  Sidhu M.D.", "age": 34, "title": "Founder & Director", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 1011553, "exercisedValue": 0, "unexercisedValue": 4233000}, {"maxAge": 1, "name": "Ms. Kimberly Ann Davis J.D.", "age": 56, "title": "COO, Chief Legal Officer & Corporate Secretary", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 653839, "exercisedValue": 0, "unexercisedValue": 123066}, {"maxAge": 1, "name": "Dr. Kiran  Nistala MBBS, Ph.D.", "age": 51, "title": "Chief Medical Officer & Head of Development", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 597411, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Hyllengren", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary  Whale Ph.D.", "age": 50, "title": "Chief Technology Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Theresa  Lowry", "age": 50, "title": "Chief Human Resources Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 3, "overallRisk": 6, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.12, "open": 2.12, "dayLow": 1.98, "dayHigh": 2.12, "regularMarketPreviousClose": 2.12, "regularMarketOpen": 2.12, "regularMarketDayLow": 1.98, "regularMarketDayHigh": 2.12, "payoutRatio": 0.0, "beta": -0.06, "forwardPE": -2.7567568, "volume": 179662, "regularMarketVolume": 179662, "averageVolume": 693022, "averageVolume10days": 408740, "averageDailyVolume10Day": 408740, "bid": 1.99, "ask": 2.08, "bidSize": 1, "askSize": 1, "marketCap": 132636920, "fiftyTwoWeekLow": 0.97, "fiftyTwoWeekHigh": 5.07, "fiftyDayAverage": 1.5212, "twoHundredDayAverage": 1.687635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -8649162, "profitMargins": 0.0, "floatShares": 37881471, "sharesOutstanding": 65018100, "sharesShort": 544611, "sharesShortPriorMonth": 585928, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0084, "heldPercentInsiders": 0.27749002, "heldPercentInstitutions": 0.51240003, "shortRatio": 0.68, "shortPercentOfFloat": 0.0092, "impliedSharesOutstanding": 67567800, "bookValue": 2.029, "priceToBook": 1.0054214, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -65425000, "trailingEps": -0.74, "forwardEps": -0.74, "enterpriseToEbitda": 0.12, "52WeekChange": -0.5, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 2.04, "targetHighPrice": 16.0, "targetLowPrice": 2.0, "targetMeanPrice": 10.8, "targetMedianPrice": 11.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 154490000, "totalCashPerShare": 2.376, "ebitda": -72339000, "totalDebt": 0, "quickRatio": 8.263, "currentRatio": 8.397, "returnOnAssets": -0.26046, "returnOnEquity": -0.43553, "freeCashflow": -24324376, "operatingCashflow": -43570000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ZURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketPrice": 2.04, "marketState": "CLOSED", "exchange": "NCM", "shortName": "Zura Bio Limited", "longName": "Zura Bio Limited", "corporateActions": [], "postMarketTime": 1756503728, "regularMarketTime": 1756497601, "regularMarketChangePercent": -3.77358, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1679405400000, "postMarketChangePercent": -1.96078, "postMarketPrice": 2.0, "postMarketChange": -0.04, "regularMarketChange": -0.0799999, "regularMarketDayRange": "1.98 - 2.12", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 693022, "fiftyTwoWeekLowChange": 1.0699999, "fiftyTwoWeekLowChangePercent": 1.1030927, "fiftyTwoWeekRange": "0.97 - 5.07", "fiftyTwoWeekHighChange": -3.0300002, "fiftyTwoWeekHighChangePercent": -0.5976332, "fiftyTwoWeekChangePercent": -50.0, "earningsTimestamp": 1754971200, "earningsTimestampStart": 1762432200, "earningsTimestampEnd": 1762432200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.74, "epsForward": -0.74, "fiftyDayAverageChange": 0.5188, "fiftyDayAverageChangePercent": 0.34104657, "twoHundredDayAverageChange": 0.35236502, "twoHundredDayAverageChangePercent": 0.20879221, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-03-21", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "messageBoardId": "finmb_1783060399", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Zura Bio", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]